Methotrexate-associated Lymphoproliferative Disorder: A Rare Differential Diagnosis of Wheezes

Intern Med. 2019 Jun 15;58(12):1759-1764. doi: 10.2169/internalmedicine.2080-18. Epub 2019 Feb 1.

Abstract

A 70-year-old woman was admitted for the evaluation of wheezes and a nodular lesion in the left lung field. She had been diagnosed with rheumatoid arthritis at 45 years of age and was continuously treated with methotrexate (MTX) at 8 mg/week. Bronchoscopic aspiration histology of a hilar lymph node suggested a lymphoproliferative disorder (LPD). After discontinuation of MTX, the lung nodule and wheezes disappeared. Although wheezes are not a usual manifestation of LPD, her clinical course clearly demonstrated an obvious relationship between LPD-induced airway narrowing and wheezes.

Keywords: Epstein-Barr virus; lymphoproliferative disorder; methotrexate; rheumatoid arthritis; wheezes.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy
  • Diagnosis, Differential
  • Female
  • Humans
  • Lymphoproliferative Disorders / chemically induced*
  • Methotrexate / adverse effects*
  • Methotrexate / therapeutic use
  • Respiratory Sounds / etiology

Substances

  • Antirheumatic Agents
  • Methotrexate